180 related articles for article (PubMed ID: 27002295)
1. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
Lee HS; Kwon JY; Joo CK
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
[TBL] [Abstract][Full Text] [Related]
2. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
[TBL] [Abstract][Full Text] [Related]
3. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
[TBL] [Abstract][Full Text] [Related]
4. Traffic-related particulate matter aggravates ocular allergic inflammation by mediating dendritic cell maturation.
Hwang M; Han S; Seo JW; Jeon KJ; Lee HS
J Toxicol Environ Health A; 2021 Aug; 84(16):661-673. PubMed ID: 33998398
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
Lee HJ; Kim BM; Shin S; Kim TY; Chung SH
Clin Immunol; 2017 Mar; 176():49-54. PubMed ID: 28063939
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model.
Mello CB; Ramos L; Gimenes AD; Andrade TR; Oliani SM; Gil CD
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):693-704. PubMed ID: 25574053
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
Chung SH; Choi SH; Choi JA; Chuck RS; Joo CK
Mol Vis; 2012; 18():1966-72. PubMed ID: 22876123
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis.
Gimenes AD; Andrade TR; Mello CB; Ramos L; Gil CD; Oliani SM
Exp Eye Res; 2015 May; 134():24-32. PubMed ID: 25795053
[TBL] [Abstract][Full Text] [Related]
9. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis.
Chung SH; Choi SH; Cho KJ; Joo CK
Clin Exp Immunol; 2011 May; 164(2):275-81. PubMed ID: 21391988
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
Shii D; Nakagawa S; Shinomiya K; Yoshimi M; Katsuta O; Oda T; Nakamura M
Curr Eye Res; 2009 Jun; 34(6):426-37. PubMed ID: 19899977
[TBL] [Abstract][Full Text] [Related]
12. Development of Allergic Conjunctivitis Induced by House Dust Mite Extract From Dermatophagoides pteronyssinus.
Lee YJ; Han SJ; Lee H; Kim JS; Seo KY
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1773-81. PubMed ID: 27074380
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin attenuates Th2-driven experimental allergic conjunctivitis.
Shin S; Lee JH; Lee HJ; Chang SY; Chung SH
Clin Immunol; 2018 May; 190():1-10. PubMed ID: 29432811
[TBL] [Abstract][Full Text] [Related]
14. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
[TBL] [Abstract][Full Text] [Related]
15. Inducing ocular allergy with beta-lactoglobulin: a new experimental model.
Sari A; Dinc E; Yilmaz BC; Adiguzel U; Oztuna S; Tasdelen B
Ophthalmic Res; 2010; 44(2):119-24. PubMed ID: 20523103
[TBL] [Abstract][Full Text] [Related]
16. The C-C chemokine receptor 6 (CCR6) is crucial for Th2-driven allergic conjunctivitis.
Chung SH; Chang SY; Lee HJ; Choi SH
Clin Immunol; 2015 Dec; 161(2):110-9. PubMed ID: 26307432
[TBL] [Abstract][Full Text] [Related]
17. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Biochem Biophys Res Commun; 2006 Jan; 339(4):1048-55. PubMed ID: 16337148
[TBL] [Abstract][Full Text] [Related]
18. TRPV1 Antagonist Suppresses Allergic Conjunctivitis in a Murine Model.
Kwon JY; Lee HS; Joo CK
Ocul Immunol Inflamm; 2018; 26(3):440-448. PubMed ID: 27726468
[TBL] [Abstract][Full Text] [Related]
19. Restoring conjunctival tolerance by topical nuclear factor-κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice.
Guzmán M; Sabbione F; Gabelloni ML; Vanzulli S; Trevani AS; Giordano MN; Galletti JG
Invest Ophthalmol Vis Sci; 2014 Sep; 55(9):6116-26. PubMed ID: 25190648
[TBL] [Abstract][Full Text] [Related]
20. An inhibitor peptide of toll-like receptor 2 shows therapeutic potential for allergic conjunctivitis.
Xu C; He X; Liu W; Chen Y; Zhou C; Duan Z; Lu Q; Yan X; Zhang Z; Zheng R
Int Immunopharmacol; 2017 May; 46():9-15. PubMed ID: 28246054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
